Financial results - ENDOGYN SRL

Financial Summary - Endogyn Srl
Unique identification code: 14672443
Registration number: J26/432/2002
Nace: 8622
Sales - Ron
14.767
Net Profit - Ron
3.722
Employee
2
The most important financial indicators for the company Endogyn Srl - Unique Identification Number 14672443: sales in 2023 was 14.767 euro, registering a net profit of 3.722 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Endogyn Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 14.146 15.984 16.013 14.582 11.579 11.742 14.050 17.577 15.056 14.767
Total Income - EUR 14.146 15.984 16.013 14.582 11.579 13.626 14.050 17.577 15.056 14.767
Total Expenses - EUR 13.867 13.235 18.942 17.040 12.530 12.692 13.753 8.165 7.067 10.145
Gross Profit/Loss - EUR 279 2.750 -2.929 -2.458 -950 935 297 9.412 7.989 4.622
Net Profit/Loss - EUR 279 2.270 -3.410 -2.896 -1.298 526 29 9.119 7.569 3.722
Employees 0 0 2 2 0 0 1 0 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -1.6%, from 15.056 euro in the year 2022, to 14.767 euro in 2023. The Net Profit decreased by -3.825 euro, from 7.569 euro in 2022, to 3.722 in the last year.

Check the financial reports for the company - Endogyn Srl

Rating financiar

Financial Rating -
Endogyn Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Endogyn Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endogyn Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Endogyn Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endogyn Srl - CUI 14672443

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 23.596 17.447 29.303 18.696 12.401 6.774 2.260 495 109 34.690
Current Assets 1.471 167 742 97 1.415 491 577 2.635 10.356 517
Inventories 0 0 0 0 853 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 7.544 0
Cash 1.471 167 742 97 562 491 577 2.635 2.812 517
Shareholders Funds -2.076 177 -3.235 -6.076 -7.261 -6.595 -6.441 2.821 7.612 3.790
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 27.143 17.438 33.280 24.868 21.077 13.860 9.277 309 2.853 31.417
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 517 euro in 2023 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 517 euro.
The company's Equity was valued at 3.790 euro, while total Liabilities amounted to 31.417 euro. Equity decreased by -3.799 euro, from 7.612 euro in 2022, to 3.790 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Endogyn Srl

Comments - Endogyn Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.